Sildenafil Citrate Tablet
Product Images NDC 71205-795

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 71205-795). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-795-30 (Sildenafil Citrate 50 mg 30s)

Label for Sildenafil 50 mg tablets by Proficient Rx LP. The label states each tablet contains Sildenafil citrate USP equivalent to 50 mg Sildenafil. Package count is 30 tablets. The tablets are described as pale blue to blue, caplet-shaped, film-coated with '1A2' debossed on one side and plain on the other. Manufacturer is Umedica Laboratories Pvt. Ltd., India.*

FDA Label Image

Sildenafil-citrate-figure-1 (Sildenafil Citrate Figure 1)

A line graph depicting mean change from baseline in sitting systolic blood pressure over 24 hours in healthy volunteers after dosing. The x-axis shows time post dose in hours, while the y-axis shows change in systolic blood pressure in mmHg. Two lines compare sildenafil citrate 100 mg and placebo groups.*

FDA Label Image

Sildenafil-citrate-figure-2 (Sildenafil Citrate Figure 2)

A line graph titled 'Figure 2: Mean Standing Systolic Blood Pressure Change from Baseline,' showing the change in systolic blood pressure (mmHg) over an 8-hour time period after dosing. It compares two groups: Doxazosin + Placebo (blue line with circles) and Doxazosin + Sildenafil 25 mg (black line with diamonds), illustrating blood pressure changes relative to baseline.*

FDA Label Image

Sildenafil-citrate-figure-3 (Sildenafil Citrate Figure 3)

A line graph displaying mean standing systolic blood pressure change from baseline over 8 hours. Two treatment groups are compared: Doxazosin plus placebo and Doxazosin plus Sildenafil 50 mg, with time post-dose on the x-axis and change in systolic blood pressure (mmHg) on the y-axis.*

FDA Label Image

Sildenafil-citrate-figure-4 (Sildenafil Citrate Figure 4)

A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' showing changes in mmHg over time in hours after dosing. It compares two groups: one receiving Doxazosin with Sildenafil 100 mg and the other Doxazosin with Placebo, depicting blood pressure changes from baseline across 0 to 8 hours.*

FDA Label Image

Sildenafil-citrate-figure-5 (Sildenafil Citrate Figure 5)

A line graph showing the mean plasma concentrations of Sildenafil in healthy male volunteers over time. The x-axis represents time post-dose in hours, and the y-axis shows plasma concentration in ng/mL. The graph depicts the concentration rising sharply to a peak shortly after dosing, then gradually declining over the 24-hour period. The treatment compared is Sildenafil versus a commercial tablet.*

FDA Label Image

Sildenafil-citrate-figure-6 (Sildenafil Citrate Figure 6)

Two bar charts depicting the effect on maintenance of erection by baseline score. The first chart shows sildenafil citrate results with increasing percentages of patients at endpoint across baseline scores 0 to 5. The second chart shows placebo effects with varied patient percentages across the same baseline scores. Each chart includes a legend categorizing data by scores 0 through 5.*

FDA Label Image

Sildenafil-citrate-figure-7 (Sildenafil Citrate Figure 7)

A bar chart showing the percentage of patients reporting improvement across four treatment groups: Placebo (24%), Sildenafil citrate 25 mg (63%), Sildenafil citrate 50 mg (74%), and Sildenafil citrate 100 mg (82%). The x-axis lists the treatment groups and sample sizes, while the y-axis represents percentages from 0 to 100.*

FDA Label Image

Sildenafil-citrate-strecture (Sildenafil Citrate Strecture)

Chemical structure of sildenafil citrate, the active ingredient in the medication. The diagram shows the molecular arrangement including rings and functional groups characteristic of sildenafil citrate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.